Wanna Chaijaroenkul

Pathum Thani, 12120, Thailand

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 61 publications

Gut Microbiota Modulation as a Therapeutic Strategy for Insomnia: A Systematic Review of Nutritional and Botanical Interventions.

Gut Microbiota Modulation as a Therapeutic Strategy for Insomnia: A Systematic Review of Nutritional and Botanical Interventions.

Journal: Biomolecules

Published: May 09, 2026

Targeted analysis of KRAS and CREBBP mutations uncovers a potential population-specific signature in thai patients with liver fluke-associated cholangiocarcinoma.

Targeted analysis of KRAS and CREBBP mutations uncovers a potential population-specific signature in thai patients with liver fluke-associated cholangiocarcinoma.

Journal: PloS one

Published: March 03, 2026

From MyACR to MyμAlbumin: Clinical Validation of a High-Precision, Real-Time Immunoturbidimetric PoC Device for Early Chronic Kidney Disease Detection.

From MyACR to MyμAlbumin: Clinical Validation of a High-Precision, Real-Time Immunoturbidimetric PoC Device for Early Chronic Kidney Disease Detection.

Journal: Journal of clinical laboratory analysis

Published: March 01, 2026

Synergistic Effects of Atractylodes-Derived Sesquiterpenes and Polyacetylene on Chemotherapeutic Sensitivity in Cholangiocarcinoma: Impact on Transporter Gene Expression.

Synergistic Effects of Atractylodes-Derived Sesquiterpenes and Polyacetylene on Chemotherapeutic Sensitivity in Cholangiocarcinoma: Impact on Transporter Gene Expression.

Journal: Molecules (Basel, Switzerland)

Published: February 12, 2026

An EV-Guided Multi-Compartment Proof-of-Concept Framework for Biomarker Prioritization in Cholangiocarcinoma.

An EV-Guided Multi-Compartment Proof-of-Concept Framework for Biomarker Prioritization in Cholangiocarcinoma.

Journal: Medical sciences (Basel, Switzerland)

Published: December 31, 2025

Circulating microRNAs Expression as Prognosis Biomarker of Cholangiocarcinoma.

Circulating microRNAs Expression as Prognosis Biomarker of Cholangiocarcinoma.

Journal: Asian Pacific journal of cancer prevention : APJCP

Published: June 27, 2025

MyμAlbumin: A Cutting-Edge Immunoturbidity-Based Device with Real-Time and Seamless Data Transmission for Early Detection of Chronic Kidney Disease at the Point of Care.

MyμAlbumin: A Cutting-Edge Immunoturbidity-Based Device with Real-Time and Seamless Data Transmission for Early Detection of Chronic Kidney Disease at the Point of Care.

Journal: Biosensors

Published: May 19, 2025

Exploring γδ T-Cell Responses in Malaria and Tuberculosis: Implications for Immunity, Coinfection, and Disease Management.

Exploring γδ T-Cell Responses in Malaria and Tuberculosis: Implications for Immunity, Coinfection, and Disease Management.

Journal: The American journal of tropical medicine and hygiene

Published: May 13, 2025

Urinary Albumin-to-Creatinine Ratio (uACR) Point-of-Care (POC) Device with Seamless Data Transmission for Monitoring the Progression of Chronic Kidney Disease.

Urinary Albumin-to-Creatinine Ratio (uACR) Point-of-Care (POC) Device with Seamless Data Transmission for Monitoring the Progression of Chronic Kidney Disease.

Journal: Biosensors

Published: January 26, 2025

A Proteomics and Metabolomics-based Approach to Biomarkers Identification for the Early Diagnosis of Cholangiocarcinoma in a Hamster Model: A Preliminary Study.

A Proteomics and Metabolomics-based Approach to Biomarkers Identification for the Early Diagnosis of Cholangiocarcinoma in a Hamster Model: A Preliminary Study.

Journal: Asian Pacific journal of cancer prevention : APJCP

Published: December 05, 2024

MyACR: A Point-of-Care Medical Device for Determination of Albumin-Creatinine Ratio (uACR) in Random Urine Samples as a Marker of Nephropathy.

MyACR: A Point-of-Care Medical Device for Determination of Albumin-Creatinine Ratio (uACR) in Random Urine Samples as a Marker of Nephropathy.

Journal: Diagnostics (Basel, Switzerland)

Published: April 25, 2024

Tumor necrosis factor-α (TNF-α) -308G >a promoter polymorphism (rs1800629) promotes Asians in susceptibility to Plasmodium falciparum severe malaria: A meta-analysis.

Tumor necrosis factor-α (TNF-α) -308G >a promoter polymorphism (rs1800629) promotes Asians in susceptibility to Plasmodium falciparum severe malaria: A meta-analysis.

Journal: PLoS neglected tropical diseases

Published: May 16, 2023

Showing 1-12 of 61

Last Updated: 09/26/2026